A detailed history of Commonwealth Equity Services, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 4,693,123 shares of PFE stock, worth $120 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
4,693,123
Previous 4,674,925 0.39%
Holding current value
$120 Million
Previous $131 Million 3.83%
% of portfolio
0.21%
Previous 0.21%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$27.7 - $31.39 $504,084 - $571,235
18,198 Added 0.39%
4,693,123 $136 Million
Q2 2024

Jul 31, 2024

BUY
$25.26 - $29.6 $3.01 Million - $3.53 Million
119,109 Added 2.61%
4,674,925 $131 Million
Q1 2024

Apr 29, 2024

BUY
$25.89 - $29.73 $6.89 Million - $7.91 Million
266,221 Added 6.21%
4,555,816 $126 Million
Q4 2023

Feb 06, 2024

SELL
$26.13 - $33.94 $8.72 Million - $11.3 Million
-333,757 Reduced 7.22%
4,289,595 $123 Million
Q3 2023

Oct 23, 2023

BUY
$32.09 - $37.51 $248,472 - $290,439
7,743 Added 0.17%
4,623,352 $153 Million
Q2 2023

Aug 10, 2023

BUY
$36.12 - $41.79 $5.46 Million - $6.32 Million
151,295 Added 3.39%
4,615,609 $169 Million
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $3.43 Million - $4.47 Million
87,173 Added 1.99%
4,464,314 $182 Million
Q4 2022

Feb 07, 2023

BUY
$41.75 - $54.5 $1.23 Million - $1.61 Million
29,577 Added 0.68%
4,377,141 $224 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $2.56 Million - $3.12 Million
-58,498 Reduced 1.33%
4,347,564 $190 Million
Q2 2022

Jul 19, 2022

BUY
$46.53 - $55.17 $3.18 Million - $3.77 Million
68,267 Added 1.57%
4,406,062 $231 Million
Q1 2022

May 04, 2022

BUY
$45.75 - $56.69 $456,951 - $566,219
9,988 Added 0.23%
4,337,795 $225 Million
Q4 2021

Jan 31, 2022

BUY
$41.32 - $61.25 $5.36 Million - $7.95 Million
129,783 Added 3.09%
4,327,807 $256 Million
Q3 2021

Oct 29, 2021

BUY
$39.25 - $50.42 $3.44 Million - $4.41 Million
87,553 Added 2.13%
4,198,024 $181 Million
Q2 2021

Aug 11, 2021

BUY
$35.91 - $40.68 $5.66 Million - $6.41 Million
157,678 Added 3.99%
4,110,471 $161 Million
Q1 2021

May 04, 2021

BUY
$33.49 - $37.77 $7.03 Million - $7.92 Million
209,804 Added 5.61%
3,952,793 $143 Million
Q4 2020

Feb 11, 2021

BUY
$33.47 - $42.56 $6.7 Million - $8.52 Million
200,238 Added 5.65%
3,742,989 $138 Million
Q3 2020

Nov 05, 2020

BUY
$31.75 - $37.25 $11 Million - $12.9 Million
346,310 Added 10.83%
3,542,751 $130 Million
Q2 2020

Aug 12, 2020

BUY
$30.12 - $36.54 $6.23 Million - $7.56 Million
206,918 Added 6.92%
3,196,441 $105 Million
Q1 2020

May 11, 2020

BUY
$27.03 - $38.62 $695,184 - $993,267
25,719 Added 0.87%
2,989,523 $97.6 Million
Q4 2019

Feb 05, 2020

BUY
$32.92 - $37.36 $4.33 Million - $4.91 Million
131,451 Added 4.64%
2,963,804 $116 Million
Q3 2019

Oct 30, 2019

BUY
$32.49 - $42.13 $510,352 - $661,778
15,708 Added 0.56%
2,832,353 $102 Million
Q2 2019

Jul 19, 2019

BUY
$36.98 - $41.52 $713,381 - $800,962
19,291 Added 0.69%
2,816,645 $122 Million
Q1 2019

May 13, 2019

BUY
$37.5 - $41.2 $3.46 Million - $3.8 Million
92,271 Added 3.41%
2,797,354 $119 Million
Q4 2018

Feb 11, 2019

BUY
$38.47 - $43.86 $531,463 - $605,925
13,815 Added 0.51%
2,705,083 $118 Million
Q3 2018

Nov 06, 2018

SELL
$34.47 - $41.81 $1.43 Million - $1.74 Million
-41,600 Reduced 1.52%
2,691,268 $119 Million
Q2 2018

Jul 31, 2018

BUY
$32.98 - $35.16 $2.19 Million - $2.33 Million
66,315 Added 2.49%
2,732,868 $98.3 Million
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $3.07 Million - $3.56 Million
96,268 Added 3.75%
2,666,553 $94.6 Million
Q4 2017

Feb 12, 2018

BUY
$33.26 - $35.29 $85.5 Million - $90.7 Million
2,570,285
2,570,285 $93.1 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.